Y Morimoto1, S M Conroy2, N J Ollberding3, Y Kim1, U Lim1, R V Cooney4, A A Franke1, L R Wilkens1, B Y Hernandez1, M T Goodman5, B E Henderson6, L N Kolonel1, L Le Marchand1, G Maskarinec1. 1. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. 2. Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Canada. 3. Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 4. Public Health Sciences, University of Hawaii, Honolulu, HI, USA. 5. Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute and Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. 6. Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Abstract
BACKGROUND: Ethnic disparities in metabolic disease risk may be the result of differences in circulating adipokines and inflammatory markers related to ethnic variations in obesity and body fat distribution. SUBJECTS/ METHODS: In a cross-sectional design, we compared serum levels of leptin, adiponectin, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in control subjects (321 men and 930 women) from two nested case-control studies conducted within the Multiethnic Cohort Study consisting of whites, Japanese Americans (JA), Latinos, African Americans (AA) and Native Hawaiians (NH). General linear models were applied to evaluate ethnic differences in log-transformed serum biomarker levels before and after adjusting for body mass index (BMI) at cohort entry. RESULTS: In comparison to whites, significant ethnic differences were observed for all biomarkers except TNF-α. JA men and women had significantly lower leptin and CRP levels than whites, and JA women also had lower adiponectin levels. Leptin was significantly higher in AA women (P < 0.01), adiponectin was significantly lower in AA men and women (P = 0.02 and P < 0.001), and CRP and IL-6 were significantly higher in AA men and women. Lower adiponectin (P < 0.0001) and CRP (P = 0.03) levels were the only biomarkers in NH women that differed from whites; no statistically significant differences were seen for NH men and for Latino men and women. When adjusted for BMI at cohort entry, the differences between the lowest and the highest values across ethnic groups decreased for all biomarkers except adiponectin in men indicating that ethnic differences were partially due to weight status. CONCLUSIONS: These findings demonstrate the ethnic variations in circulating adipokine and CRP levels before and after adjustment for BMI. Given the limitation of BMI as a general measure of obesity, further investigation with visceral and subcutaneous adiposity measures are warranted to elucidate ethnicity-related differences in adiposity in relation to disparities in obesity-related disease risk.
BACKGROUND: Ethnic disparities in metabolic disease risk may be the result of differences in circulating adipokines and inflammatory markers related to ethnic variations in obesity and body fat distribution. SUBJECTS/ METHODS: In a cross-sectional design, we compared serum levels of leptin, adiponectin, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in control subjects (321 men and 930 women) from two nested case-control studies conducted within the Multiethnic Cohort Study consisting of whites, Japanese Americans (JA), Latinos, African Americans (AA) and Native Hawaiians (NH). General linear models were applied to evaluate ethnic differences in log-transformed serum biomarker levels before and after adjusting for body mass index (BMI) at cohort entry. RESULTS: In comparison to whites, significant ethnic differences were observed for all biomarkers except TNF-α. JA men and women had significantly lower leptin and CRP levels than whites, and JA women also had lower adiponectin levels. Leptin was significantly higher in AA women (P < 0.01), adiponectin was significantly lower in AA men and women (P = 0.02 and P < 0.001), and CRP and IL-6 were significantly higher in AA men and women. Lower adiponectin (P < 0.0001) and CRP (P = 0.03) levels were the only biomarkers in NH women that differed from whites; no statistically significant differences were seen for NH men and for Latino men and women. When adjusted for BMI at cohort entry, the differences between the lowest and the highest values across ethnic groups decreased for all biomarkers except adiponectin in men indicating that ethnic differences were partially due to weight status. CONCLUSIONS: These findings demonstrate the ethnic variations in circulating adipokine and CRP levels before and after adjustment for BMI. Given the limitation of BMI as a general measure of obesity, further investigation with visceral and subcutaneous adiposity measures are warranted to elucidate ethnicity-related differences in adiposity in relation to disparities in obesity-related disease risk.
Authors: Y Nakamura; H Ueshima; N Okuda; K Miura; Y Kita; T Okamura; T C Turin; A Okayama; B Rodriguez; J D Curb; J Stamler Journal: Nutr Metab Cardiovasc Dis Date: 2010-08-03 Impact factor: 4.222
Authors: Yukiko Morimoto; Shannon M Conroy; Nicholas J Ollberding; Susanne M Henning; Adrian A Franke; Lynne R Wilkens; Marc T Goodman; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel; Gertraud Maskarinec Journal: Cancer Causes Control Date: 2012-08-21 Impact factor: 2.506
Authors: Shannon M Conroy; Gertraud Maskarinec; Yukiko Morimoto; Adrian A Franke; Robert V Cooney; Lynne R Wilkens; Marc T Goodman; Brenda Y Hernadez; Loïc Le Marchand; Brian E Henderson; Laurence N Kolonel Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-08 Impact factor: 4.254
Authors: Andrew Mente; David Meyre; Matthew B Lanktree; Mahyar Heydarpour; A Darlene Davis; Ruby Miller; Hertzel Gerstein; Robert A Hegele; Salim Yusuf; Sonia S Anand Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240
Authors: Shannon M Conroy; Weiwen Chai; Unhee Lim; Adrian A Franke; Robert V Cooney; Gertraud Maskarinec Journal: Mediators Inflamm Date: 2011-02-08 Impact factor: 4.711
Authors: Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne Journal: Brain Behav Immun Date: 2018-06-19 Impact factor: 7.217
Authors: M Bethel; P Bůžková; H A Fink; J A Robbins; J A Cauley; J Lee; J I Barzilay; D I Jalal; L D Carbone Journal: Osteoporos Int Date: 2015-12-11 Impact factor: 4.507
Authors: Marilyn L Kwan; Song Yao; Valerie S Lee; Janise M Roh; Qianqian Zhu; Isaac J Ergas; Qian Liu; Yali Zhang; Susan E Kutner; Charles P Quesenberry; Christine B Ambrosone; Lawrence H Kushi Journal: Breast Cancer Res Treat Date: 2016-07-22 Impact factor: 4.872